Ten Stocks That Trended on Discord This Weekend: OEG, AMZN, VTGN, TSLA, AMD, AMC, OXY, BBIG, SIGA, GOVX
$AMC
$AMD
$AMZN
$BBIG
Movies/Entertainment
Consumer Discretionary
Semiconductors
Technology
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/14/2024 | $210.00 → $250.00 | Buy | Needham | |
| 11/11/2024 | $15.00 | Buy | Alliance Global Partners | |
| 11/8/2024 | $56.00 | Neutral | JP Morgan | |
| 11/1/2024 | $215.00 → $235.00 | Outperform | Telsey Advisory Group | |
| 11/1/2024 | $225.00 → $245.00 | Buy | Monness Crespi & Hardt | |
| 10/30/2024 | $210.00 → $185.00 | Buy | TD Cowen | |
| 10/24/2024 | $120.00 → $125.00 | Underweight | Wells Fargo | |
| 10/24/2024 | $236.00 → $238.00 | Hold | Truist |
8-K - ADVANCED MICRO DEVICES INC (0000002488) (Filer)
8-K - GeoVax Labs, Inc. (0000832489) (Filer)
144 - Tesla, Inc. (0001318605) (Subject)
Leading tech companies to collaborate on architectural interoperability and simplify software development across the ecosystem; luminaries Linus Torvalds and Tim Sweeney join founding members Broadcom, Dell, Google, Hewlett Packard Enterprise, HP Inc., Lenovo, Meta, Microsoft, Oracle, and Red Hat. Intel Corp. (INTC) and AMD (NASDAQ:AMD) today announced the creation of an x86 ecosystem advisory group bringing together technology leaders to shape the future of the world's most widely used computing architecture. x86 is uniquely positioned to meet customers' emerging needs by delivering superior performance and seamless interoperability across hardware and software platforms. The group will f
Amazon Ads announced several new capabilities that leverage its deep, full-funnel insights to help brands launch new products and extend its sophisticated measurement and optimization ad tech to all advertisers (NASDAQ:AMZN) — At unBoxed 2024, Amazon Ads launched a suite of new advertising capabilities that bring together insights from across the marketing funnel to help advertisers optimize their media investments. The announcements showcased how Amazon Ads is making its powerful insights easier to access and activate by every advertiser, across every ad product. "Our mission is to be the most customer-obsessed advertising service by giving all brands the measurement and data-driven, mac
Vistagen CEO Shawn Singh; The Goldie Hawn Foundation Founder Goldie Hawn; and MindUP students to ring the Nasdaq Closing Bell on October 10, 2024 Vistagen and The Goldie Hawn Foundation join forces to raise awareness around the roles of mindfulness and pioneering neuroscience in mental health Vistagen (NASDAQ:VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development of groundbreaking therapies for psychiatric disorders based on nose-to-brain neurocircuitry, and The Goldie Hawn Foundation's MindUP, a neuroscience-based preventative mental health program for youth, along with children from New York City schools utilizing MindUP, will join toget
For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there
SANTA CLARA, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ:AMD) announced the following events for the financial community: Forrest Norrod, executive vice president and general manager, Data Center Solutions Business Unit, will attend the UBS Annual Technology Conference on Tuesday, Dec. 3, 2024, at 12:15 PM MST.Jean Hu, executive vice president, chief financial officer and treasurer, will attend the Barclays Global TMT Conference on Thursday, Dec. 12, 2024, at 11:00 AM PST. A webcast of the presentations can be accessed on AMD's Investor Relations website ir.amd.com. About AMD For more than 50 years AMD has driven innovation in high-performance computing, graphics and vi
GEO-CM04S1 Improved Immune Response vs mRNA Vaccine ATLANTA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the completion of an interim data review by the Data Safety Monitoring Board (DSMB) for the ongoing Phase 2 clinical trial of GEO-CM04S1, GeoVax's dual-antigen next-generation COVID-19 vaccine, as a booster vaccine for patients with chronic lymphocytic leukemia (CLL). Based on the interim analysis of immune responses from the patients enrolled to date, the DSMB determined that, while the mRNA control arm of the study failed to meet the prede
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- SunCar Technology Group Inc. (NASDAQ:SDA), a leading innovator in cloud-based B2B auto services and auto e-insurance in China, is pleased to announce its inclusion in the NASDAQ Golden Dragon China Index, marking an important milestone in the Company's growth journey. The NASDAQ Golden Dragon China Index is a benchmark for tracking Chinese companies listed on U.S. exchanges, offering investors a window into the dynamic growth opportunities within China's economy, particularly in sectors like digital services, technology, new consumer markets, and clean energy. This prestigious index includes leading Chinese companies like Alibaba (NYSE:BABA), JD.com (
4 - AMAZON COM INC (0001018724) (Issuer)
4 - AMAZON COM INC (0001018724) (Issuer)
3 - ADVANCED MICRO DEVICES INC (0000002488) (Issuer)
HOUSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Occidental (NYSE:OXY) today announced its third quarter 2024 financial results. The earnings release and accompanying financial schedules can be accessed via the Investor Relations section of the company's website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission's website at sec.gov. The company will hold a conference call to discuss the results on Wednesday, November 13, 2024, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conferen
Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b trial; multiple data readouts of existing COVID-19 vaccine Phase 2 trials expected during fourth quarter 2024 Gedeptin® on track to advance into Phase 2 clinical trial for first recurrent head and neck cancer in the first half of 2025 GEO-MVA Mpox vaccine advancing with cGMP clinical batch anticipated during fourth quarter 2024 Company to host conference call and webcast today at 4:30 p.m. ET ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced financial results for the third quarter end
Fasedienol U.S. registration-directed PALISADE Phase 3 Program for acute treatment of social anxiety disorder progressing PALISADE-3 and PALISADE-4 Phase 3 trials initiated and underway Vistagen (NASDAQ:VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today reported financial results for its fiscal year 2025 second quarter ended September 30, 2024, and provided a corporate update. "We initiated our PALISADE-4 Phase 3 trial during our second quarter, achieving yet another significant milestone in our fasedienol U.S. registration-directed Phase 3 Program for the acute treatment of social anxiety disorder," said Shawn Singh, Ch
SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)
SC 13G/A - Vistagen Therapeutics, Inc. (0001411685) (Subject)
SC 13G/A - Vistagen Therapeutics, Inc. (0001411685) (Subject)
4 - GeoVax Labs, Inc. (0000832489) (Issuer)
4 - GeoVax Labs, Inc. (0000832489) (Issuer)
4 - GeoVax Labs, Inc. (0000832489) (Issuer)
Needham reiterated coverage of Amazon with a rating of Buy and set a new price target of $250.00 from $210.00 previously
Alliance Global Partners initiated coverage of GeoVax Labs with a rating of Buy and set a new price target of $15.00
JP Morgan resumed coverage of Occidental Petro with a rating of Neutral and set a new price target of $56.00
To gain an edge, this is what you need to know today. GDP Brings Buying Please click here for an enlarged chart of Invesco QQQ Trust Series 1 (NASDAQ:QQQ). Note the following: The chart shows a drop in QQQ. The drop in QQQ was triggered by speculative sentiment pulling back. As a reader of The Arora Report, you knew in advance that speculative sentiment could fall as a result of Tesla Inc (NASDAQ:TSLA) earnings. The chart shows that QQQ is approaching the support zone. RSI on the chart shows that QQQ is now oversold. Oversold markets tend to bounce. The chart shows that the volume was low on the selloff. This indicates a lack of conviction in selling. Especially hard hit in
Amazon.com Inc (NASDAQ:AMZN) shares are slightly lower Thursday. The company announced a strategic collaboration with GE HealthCare and was selected by the National Basketball Association (NBA) to telecast NBA games over the next decade. What Happened: GE HealthCare and Amazon Web Services (AWS) announced a strategic collaboration to develop foundation models and generative AI applications aimed at helping clinicians improve medical diagnostics and patient care. GE Healthcare said it will use AWS’s generative AI services to build and implement new foundation models. The models are expected to streamline healthcare operations, increase diagnostic and screening accuracy, enhance outcomes
Honda Motor Co. (NYSE:HMC) will reduce its production of gasoline vehicles in China by 19% starting this October, marking a strategic shift toward electric vehicles. The Japanese automaker will cease operations of one production line at its joint venture Dongfeng Honda, which has an annual capacity of 240,000 units, beginning in November. Additionally, in October, GAC Honda, another of its facilities with a capacity of 50,000 units annually, will be completely shut down. These changes are part of Honda's effort to accelerate the “steady shift” to EVs, reported Bloomberg. Honda’s production capacity in China, currently around 1.5 million units, will see a reduction of 19% due to
